Core Viewpoint - Nintendo's stock experienced a significant increase of over 5% due to an analyst's price-target upgrade, contrasting with the S&P 500's decline of 0.4% [1] Group 1: Analyst Upgrades - JPMorgan Chase's Junko Yamamura raised her fair value assessment for Nintendo's Japan-listed stock to 15,300 yen ($106.52) per share from 13,400 yen ($93.29), maintaining an overweight recommendation [2] - Yamamura's bullish stance has evolved over the past few months, having initially rated the stock as a buy at 11,600 yen ($0.76 per share) in January [4] Group 2: Market Sentiment - The upcoming launch of the long-awaited Switch 2 console has generated positive pre-launch buzz, contributing to the stock's support [5] - Other analysts have also increased their price targets for Nintendo, with Benchmark's Mike Hickey raising his target to 13,000 yen ($90.50) from 11,800 yen ($82.15), while CLSA's Jay Defibaugh raised his target to 8,600 yen ($59.87) from 7,800 yen ($54.30) despite maintaining a sell rating [6]

Group 1 - Impinj (PI) shares have increased by 52.5% in the past four weeks, closing at $117.52, with a mean price target of $149.50 indicating a potential upside of 27.2% [1] - The mean estimate consists of eight short-term price targets with a standard deviation of $55.04, where the lowest estimate is $100 (14.9% decline) and the highest is $251 (113.6% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 102.6% over the past month [11][12] Group 2 - The Zacks Rank for PI is 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While price targets are often viewed as important, they can mislead investors, and analysts may set overly optimistic targets due to business incentives [7][8] - A low standard deviation in price targets indicates a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]

Shares of Altimmune, Inc. (ALT) have gained 39.4% over the past four weeks to close the last trading session at $5.80, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $22.38 indicates a potential upside of 285.9%.The mean estimate comprises eight short-term price targets with a standard deviation of $5.32. While the lowest estimate of $12 indicates a 106.9% increase from the cur ...

Astrazeneca (AZN) closed the last trading session at $67.30, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $86.07 indicates a 27.9% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $10.38. While the lowest estimate of $67 indicates a 0.5% decline from the current price level, the most optimistic analyst expects the ...

Shares of Upbound Group (UPBD) have gained 10.1% over the past four weeks to close the last trading session at $24.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37.88 indicates a potential upside of 56.7%.The average comprises eight short-term price targets ranging from a low of $30 to a high of $50, with a standard deviation of $7.12. While the lowest estimate indicates ...

Howard Hughes Holdings (HHH) closed the last trading session at $67.47, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $90.67 indicates a 34.4% upside potential.The average comprises three short-term price targets ranging from a low of $82 to a high of $105, with a standard deviation of $12.50. While the lowest estimate indicates an increase of 21.5% from the current ...

Financial Performance - Sportsman's Warehouse is expected to report a quarterly loss of 6 cents per share for Q4, compared to a loss of 2 cents per share in the same quarter last year [1] - Projected quarterly revenue is $328.67 million, down from $370.39 million a year earlier [1] Recent Developments - On March 12, Sportsman's Warehouse announced that customers can now purchase suppressors online through a partnership with Silencer Central [2] - The company's shares fell by 1.6%, closing at $0.9941 on Monday [2] Analyst Ratings - Craig-Hallum analyst Ryan Sigdahl maintained a Hold rating and reduced the price target from $4 to $3 [5] - Baird analyst Peter Benedict maintained a Neutral rating and cut the price target from $4 to $2.5 [5]